[Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
OBJECTIVE: To investigate the role of substance P(SP) of the nonadrenergic system within airways in the pathogenesis of COPD, and analyze the relationship between level of SP and FEV1/FVC in COPD patients. METHOD: SP concentration in sputum and plasma in 20 patients with COPD and 20 normal volunteers was examined and was measured by radioimmunoassay. RESULTS: The sputum SP concentration was significantly higher in patients with COPD (57.3 +/- 14.5) pmol/L than that in normal volunteers(5.9 +/- 2.6) pmol/L, P < 0.01, the plasma SP concentration was significantly higher in COPD patients (8.6 +/- 3.9) pmol/L than that in normal volunteers (3.8 +/- 2.0) pmol/L, P < 0.05. The plasma and sputum SP concentration correlated with FEV1/FVC in COPD patients (r = -0.591, r = -0.642, P < 0.05). CONCLUSION: These data suggest that neurogenic inflammation may be involved in the airway inflammation process and subsequent airway narrowing in COPD.